Alzheimer's Disease
From Proteopedia
(Difference between revisions)
Line 14: | Line 14: | ||
*[[SANDBOX138|Human APP Intracellular Domain Complex with Fe65-PTB2]] | *[[SANDBOX138|Human APP Intracellular Domain Complex with Fe65-PTB2]] | ||
*[[Flexibility of aromatic residues in acetylcholinesterase|Aromatic Residue Flexibility in AChE]] | *[[Flexibility of aromatic residues in acetylcholinesterase|Aromatic Residue Flexibility in AChE]] | ||
- | *[[Beta Amyloid]] | ||
*[[Acetylcholine binding protein]] (AChBP) | *[[Acetylcholine binding protein]] (AChBP) | ||
*Drug Compounds & Substrates | *Drug Compounds & Substrates | ||
Line 44: | Line 43: | ||
***[[1ut6|N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE Complexed with Acetylcholinesterase]] | ***[[1ut6|N-9-(1',2',3',4'-TETRAHYDROACRIDINYL)-1,8-DIAMINOOCTANE Complexed with Acetylcholinesterase]] | ||
***[[1jjb|PEG-SH Complexed with Acetylcholinesterase]] | ***[[1jjb|PEG-SH Complexed with Acetylcholinesterase]] | ||
- | *[[Gamma-Secratase]] | ||
*[[Monoamine oxidase b|Monamine Oxidase B]] | *[[Monoamine oxidase b|Monamine Oxidase B]] | ||
*Glutamate Receptor | *Glutamate Receptor |
Revision as of 18:07, 20 October 2010
Alzheimer's Disease, is the most common form of dementia, especially in individuals over 65 years old. It is predicted to affect 1 in 85 people by 2050.
Articles in Proteopedia concerning Alzheimer's Disease include:
To view Alzheimer's Disease related proteins which are Structure Index entries see:
To view automatically seeded indices concerning Alzheimer's Disease See:
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky, Wayne Decatur